|
|
Volumn 105, Issue , 2001, Pages 277-302
|
|
Thymic malignancies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL RESPONSE MODIFIER;
CISPLATIN;
CORTICOSTEROID;
IFOSFAMIDE;
INTERLEUKIN 2;
ADJUVANT THERAPY;
AGAMMAGLOBULINEMIA;
AUTOIMMUNE DISEASE;
CANCER STAGING;
CARCINOMA;
CLASSIFICATION;
CLINICAL TRIAL;
CYTOLOGY;
EPITHELIUM CELL;
HUMAN;
MULTICENTER STUDY;
MYASTHENIA GRAVIS;
PARANEOPLASTIC SYNDROME;
PATHOLOGY;
PRENATAL DEVELOPMENT;
PURE RED CELL ANEMIA;
REVIEW;
SECOND CANCER;
THYMECTOMY;
THYMOMA;
THYMUS;
TREATMENT OUTCOME;
THYMOMA;
ADRENAL CORTEX HORMONES;
AGAMMAGLOBULINEMIA;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AUTOIMMUNE DISEASES;
BIOLOGICAL RESPONSE MODIFIERS;
CARCINOMA;
CISPLATIN;
CLINICAL TRIALS;
EPITHELIAL CELLS;
HUMANS;
IFOSFAMIDE;
INTERLEUKIN-2;
MULTICENTER STUDIES;
MYASTHENIA GRAVIS;
NEOPLASM STAGING;
NEOPLASMS, SECOND PRIMARY;
PARANEOPLASTIC SYNDROMES;
RADIOTHERAPY, ADJUVANT;
RED-CELL APLASIA, PURE;
THYMECTOMY;
THYMUS GLAND;
THYMUS NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 0035220891
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-1589-0_11 Document Type: Review |
|
Times cited : (17)
|
|
References (120)
|